Structure-Activity Relationships and Drug Design
Quantitative Aspects of Drug-Receptor Interaction
Pharmacodynamic Models: Overview
Pharmacokinetic Models: Comparison and Selection Criterion
Molecular Models
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 17, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
1QSAR Research Unit in Environmental Chemistry and Ecotoxicology, Theoretical and Applied Sciences, University of Insubria, via Dunant 3, Varese, Italy. paola.gramatica@uninsubria.it
This chapter outlines best practices for developing and validating Quantitative Structure-Activity Relationship (QSAR) models. It emphasizes statistical quality and external predictive power for reliable compound predictions.
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
05:50Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: